Cite
HARVARD Citation
Alexander, T. et al. (n.d.). 06.14 Proteasome inhibition with bortezomib in sle promotes therapeutically relevant depletion of short- and long-lived plasma cells but does not prevent their regeneration. Annals of the rheumatic diseases. p. A65. [Online].